DS
IART icon

David Shaw’s Integra LifeSciences IART Stock Holding History

David Shaw’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-20,000
Closed -$893K – 4098
2020
Q1 		$893K Buy
+20,000
New +$1.05M ﹤0.01% 2819

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

David Shaw's IART Position: Q2 2026 in Review

David Shaw increased its Integra LifeSciences (IART) stake by 30% in Q2 2026, buying an estimated $1.65M and bringing the position to 507,252 shares worth $9.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1895.

David Shaw first reported a position in IART in Q4 2013 and has held it in 50 quarters since. The position peaked at $33M in Q2 2018. 211 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • David Shaw held 507,252 shares of Integra LifeSciences worth $9.11M as of Q2 2026.
  • David Shaw bought 117,753 Integra LifeSciences shares in Q2 2026, an estimated $1.65M.
  • Integra LifeSciences made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #1895 holding.
  • David Shaw first reported a position in Integra LifeSciences in Q4 2013 and has held it in 50 quarters since.
  • David Shaw's Integra LifeSciences position peaked at $33M in Q2 2018.
  • 211 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.